Trial Profile
A Phase I study of remimazolam (fourth trial to complement the phase 3 trials)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Mar 2017
Price :
$35
*
At a glance
- Drugs Remimazolam (Primary)
- Indications Sedation
- Focus Adverse reactions
- 23 Mar 2017 New trial record